Nanion Technologies and Assay.Works partner to offer drug discovery services for membrane transporter targets
Nanion Technologies, a leading provider of automated electrophysiology systems, today announced the partnership with Ass…
Nanion Technologies, a leading provider of automated electrophysiology systems, today announced the partnership with Ass…
According to a recent survey among automated patch clamp users, performed by HTStec Ltd., respondents favour Nanion’s in…
Dr. Costantin has a solid and highly impressive track record in customer relation management, in-depth knowledge of ion…
Nanion Technologies, an innovative German-based company providing high quality devices for ion channel research and drug…
The SyncroPatch 384/768PE offers the highest throughput in automated patch clamping history. The SyncroPatch 384/768PE f…
Nanion Technologies, a leading provider of automated patch clamp platforms, and Axion Biosystems, originator of the firs…
Nanion recently introduced the SyncroPatch 384 Patch Engine (PE), an instrument for HTS-compatible ion channel screening…
The brand-new SyncroPatch 384 Patch Engine (PE) now released by Nanion Technologies propels ion channel drug discovery t…
Stem cell derived cardiomyocytes have tremendous potential for cardiac safety testing of drug candidates. By offering an…
The SyncroPatch 96, a high quality, high throughput patch clamp ion channel screening platform, shows impressive results…